Tacke, MD, PhD, U., Uosukainen, MSci (Pharm), H., Kananen, BSci (Pharm), M., Kontra, Pharm Lic, K., & Pentikäinen, MD, H. (2018). A pilot study about the feasibility and cost-effectiveness of electronic compliance monitoring in substitution treatment with buprenorphine—naloxone combination. Journal of Opioid Management, 5(6), 321–329. https://doi.org/10.5055/jom.2009.0032